Recent advancements in cannabinoid research are shining a spotlight on Cannabigerol (CBG), an active compound found in hemp and cannabis sativa plants, that’s gaining attention for its potential to reduce emotional discomfort and enhance memory. A pioneering clinical trial led by researchers from Washington State University (WSU) and UCLA found that CBG may significantly reduce anxiety emotional discomfort and improve memory recall, a promising development in the world of wellness.
CBG’s Potential Unveiled
The WSU-UCLA study, published in Scientific Reports, is the first of its kind to clinically test CBG’s effects on anxiety, stress, and mood. The double-blind, placebo-controlled trial involved 34 cannabis users who reported significant reductions in anxiety within just 20 minutes of taking a 20 mg dose of CBG. Additionally, CBG was found to enhance memory recall, a rare and valuable trait in the cannabinoid family.
Importantly, the study noted that CBG did not produce the cognitive or motor impairments often associated with THC, nor did it cause significant side effects like dry mouth, sleepiness, or increased appetite. These findings align with previous survey data indicating that a majority of CBG users prefer it for anxiety relief over conventional medications.
The Advantage of Oral Thin Film
While the study focused on CBG administered via tincture, the delivery method can significantly influence the efficacy of any cannabinoid product. Clinical findings published on October 2023 by School of Life Sciences, University of Technology Sydney, Sydney, NSW 2007, Australia show that cannabis infused tinctures have a bioavailability of approximately 12% to 35%. An average of 21-23%.
This is where our sublingual oral thin films truly excel. Numerous research studies clearly show that OTF’s have a bioavailability of 75%-93%. An average of 83-85%. Further, OTFs have a faster onset time of 8-10 minutes and fully active in the bloodstream after 10-14 minutes. This means that more of the active ingredient reaches the bloodstream quickly, enhancing and prolonging its effects.
The facts and data clearly show that if an OFT was being used for this study, the dosage amount of CBG could have been some 70-75% less, be far easier to consume, and have a consistent accurate dosage. In this case, the dosage would have been 5.5mg of CBG instead of the 20mg used in the study.
Memory Enhancement and Beyond
By providing a controlled, rapid-release accurate dosage, our product supports not only anxiety and stress relief but also mental clarity—an essential factor for those dealing with the cognitive fog often associated with high-stress levels.
Safety and Efficacy
One of the standout findings from the WSU-UCLA CBG trial was its safety profile. Participants reported minimal side effects, with no cognitive or motor impairments. Our oral thin film products are designed with the same emphasis on safety, offering a controlled dosage that minimizes any adverse effects while delivering the full benefits of CBG.
A Future-Focused Approach
As research into cannabinoids like CBG continues to evolve, so too does our commitment to offering the most advanced and effective wellness solutions. Whether it’s through reducing anxiety, enhancing memory, or providing a safe and convenient delivery method, our oral thin film products are designed to meet the needs of a fast-paced world, offering a reliable alternative to traditional products like inhalants, edibles, capsules, and oils.
Conclusion
The recent CBG study underscores the growing potential of cannabinoids in wellness, but it also highlights the importance of how these compounds are delivered. Our oral thin films stand out as a superior choice for those seeking quick, effective, and safe relief. As more research emerges, we remain dedicated to leading the way in cannabinoid innovation, providing you with the best that science and nature have to offer.
Comments